Page:Interim Staff Report on Investigation into Risky MPXV Experiment at the National Institute of Allergy and Infectious Diseases.pdf/47

October 31, 2023

VIA EMAIL DELIVERY

The Honorable Cathy McMorris Rodgers
Chair
Committee on Energy and Commerce
U.S. House of Representatives
Washington, D.C. 20515

 

Dear Chair Rodgers:

The enclosed documents are a production of materials in response to your March 30, 2023 and October 20, 2023, letters to the National Institutes of Health (NIH) regarding mpox research. Today’s production bears documents in bates range: ECMPOX000001 to ECMPOX000015.

By producing these documents, the Department of Health and Human Services (HHS) is making an accommodation unique to the facts and circumstances of this particular matter in a good faith effort to assist the Committee in its inquiry. We respectfully request that the Committee not disseminate or otherwise disclose these documents outside of the Committee without prior consultation with HHS. The production of these materials does not waive any applicable privilege. Should you have any questions regarding this document production, please have your staff contact Daria Berstell at Daria.Berstellhhs.gov.

Sincerely,

A personal signature appears here

Melanie Anne Egorin, PhD
Assistant Secretary for Legislation

Enclosures

cc: The Honorable Frank Pallone, Jr., Ranking Member

47